With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...
A new study suggests that a promising noninvasive brain stimulation technique may not function exactly as psychiatrists had ...
A UNSW biomedical expert explains how neurostimulation can already treat conditions like chronic pain, Parkinson's disease and hearing loss - and why ...
One Mind™, a leading mental health nonprofit based in Napa Valley, CA, today announced the selected startups of the 2026 One Mind Accelerator, a 10-week immersive program designed to offer critical ...
IEEE Spectrum on MSN
At-home brain stimulation for depression is just the start
Flow’s headset is the first tDCS device approved by the FDA ...
PathMaker Neurosystems Inc. ('PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...
1 Northamptonshire Healthcare NHS Foundation Trust, Northampton, UK. 2 Faculty of Arts, Science and Technology (FAST), University of Northampton, Northampton, UK. tDCS may improve concentration ...
This project was funded by the Efficacy and Mechanism Evaluation (EME) Programme (NIHR130077), a Medical Research Council (MRC) and National Institute of Health and Care Research (NIHR) partnership.
What they found was that the device was safe to use but provided no significant relief of symptoms in the group receiving the treatment, compared with the short-stimulation cohort. The symptoms they ...
About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few treatment attempts, but up to one-third of patients have treatment-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results